Detalhe da pesquisa
1.
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
Hepatology
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447034
2.
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A.
Blood
; 141(10): 1147-1158, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108308
3.
Concentration-effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-test.
Br J Anaesth
; 132(2): 343-351, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925268
4.
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.
Clin Gastroenterol Hepatol
; 21(7): 1854-1863.e10, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244661
5.
Emicizumab for the treatment of acquired hemophilia A.
Blood
; 137(3): 410-419, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766881
6.
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
J Hepatol
; 76(5): 1090-1099, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066090
7.
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.
Clin Gastroenterol Hepatol
; 20(6): 1362-1373.e6, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256145
8.
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial.
Haematologica
; 107(9): 2121-2132, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818873
9.
Multicenter performance evaluation and reference range determination of a new one-stage factor VIII assay.
J Clin Lab Anal
; 36(4): e24294, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274775
10.
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer.
Int J Mol Sci
; 23(24)2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555414
11.
Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane Oxygenation.
Crit Care Med
; 49(12): e1206-e1211, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259662
12.
Safety of direct oral anticoagulants in patients with advanced liver disease.
Liver Int
; 41(9): 2159-2170, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152697
13.
Immature cell fractions after cessation of chronic P2Y12-inhibition in patients with coronary artery diseases.
Platelets
; 32(6): 815-820, 2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762577
14.
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.
Clin Chem
; 66(11): 1405-1413, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777031
15.
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.
Liver Int
; 40(6): 1415-1426, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052552
16.
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors.
Blood
; 128(2): 293-6, 2016 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27216215
17.
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.
BMC Med
; 15(1): 54, 2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28279213
18.
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
Blood
; 125(22): 3477-83, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25810488
19.
Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications.
Ann Hematol
; 96(6): 1023-1031, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28361296
20.
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.
Ann Hematol
; 96(3): 489-495, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28018998